⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 17, 2024The World Journal of Biological PsychiatryOpen Access

Lymphoblast transcriptome analysis in 22q11.2 deletion syndrome individuals with schizophrenia-spectrum disorder

Elena Michaelovsky Miri Carmel Doron Gothelf Abraham Weizman

View Full Paper

Ask AI

Bookmark

Share

Abstract

Objectives 22q11.2 deletion is the most prominent risk factor for schizophrenia (SZ). The aim of the present study was to identify unique transcriptome profile for 22q11.2 deletion syndrome (DS)-related SZ-spectrum disorder (SZ-SD).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Michaelovsky et al. (2024) studied this question.

synapsesocial.com/papers/68e73a87b6db6435876b4448 https://doi.org/10.1080/15622975.2024.2327030

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Integrative transcriptome network analysis of iPSC-derived neurons from schizophrenia and schizoaffective disorder patients with 22q11.2 deletionpreclinical · 2016 · 109 citations
2Functional Gene-Expression Analysis Shows Involvement of Schizophrenia-Relevant Pathways in Patients with 22q11 Deletion Syndromecase-control · 2012 · 35 citations
3The 22q11.2 microdeletion: Fifteen years of insights into the genetic and neural complexity of psychiatric disordersreview · 2010 · 137 citations
4miRNA-mediated risk for schizophrenia in 22q11.2 deletion syndromereview · 2012 · 41 citations
5Epigenetic factors in the 22q11.2 deletion syndrome in relation to stress and schizophrenia2024